Concerns over Ozempic misuse and eating disorder risks prompt calls for increased screening

Concerns over Ozempic misuse and eating disorder risks prompt calls for increased screening

Source: ABC News

Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.

Initially developed to treat type 2 diabetes, drugs such as Ozempic and Wegovy (brand names for semaglutide) have become household names in recent years.
They belong to a class of medications known as GLP-1 receptor agonists, which lower blood sugar … [8245 chars]

Read more